AXT (AXTI) has had the highest return between November 9, 2025 and August 9, 2026 by a mid-cap US stock, returning 803.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
AXT (AXTI) | 11/9/2025 - 8/9/2026 | 803.88% |
Erasca (ERAS) | 11/9/2025 - 8/9/2026 | 700.43% |
Sellas Life Sciences (SLS) | 11/9/2025 - 8/9/2026 | 641.36% |
Alumis (ALMS) | 11/9/2025 - 8/9/2026 | 481.05% |
Maase (MAAS) | 11/9/2025 - 8/9/2026 | 392.13% |
MaxLinear (MXL) | 11/9/2025 - 8/9/2026 | 390.71% |
Spyre Therapeutics (SYRE) | 11/9/2025 - 8/9/2026 | 357.52% |
Ichor (ICHR) | 11/9/2025 - 8/9/2026 | 342.92% |
ChronoScale (CHRN) | 11/9/2025 - 8/9/2026 | 335.14% |
Aehr Test Systems (AEHR) | 11/9/2025 - 8/9/2026 | 310.8% |
PACS (PACS) | 11/9/2025 - 8/9/2026 | 292.54% |
Definium Therapeutics (DFTX) | 11/9/2025 - 8/9/2026 | 290.03% |
Butterfly Network (BFLY) | 11/9/2025 - 8/9/2026 | 285.59% |
Twist Bioscience (TWST) | 11/9/2025 - 8/9/2026 | 271.81% |
Oruka Therapeutics (ORKA) | 11/9/2025 - 8/9/2026 | 250.8% |
Immunitybio (IBRX) | 11/9/2025 - 8/9/2026 | 248.86% |
Liquidia Technologies (LQDA) | 11/9/2025 - 8/9/2026 | 242% |
Enliven Therapeutics (ELVN) | 11/9/2025 - 8/9/2026 | 239.28% |
Veradermics (MANE) | 11/9/2025 - 8/9/2026 | 236.44% |
Tango Therapeutics (TNGX) | 11/9/2025 - 8/9/2026 | 235.86% |
Hycroft Mining (HYMC) | 11/9/2025 - 8/9/2026 | 232.17% |
10X Genomics (TXG) | 11/9/2025 - 8/9/2026 | 231.19% |
Ultra Clean (UCTT) | 11/9/2025 - 8/9/2026 | 225.2% |
Relay Therapeutics (RLAY) | 11/9/2025 - 8/9/2026 | 217.34% |
Andersen (ANDG) | 11/9/2025 - 8/9/2026 | 210.5% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.